Beam Therapeutics ($BEAM) Insider Trading & Smart Money Activity

Beam Therapeutics Inc. · Biotechnology · Latest filing Oct 16, 2026

Beam Therapeutics Inc. ($BEAM) has 5 insider trades and 3 13F position changes on file. In the last 12 months on the open market, no insider bought and 3 insiders sold ($11.23M), net -$11.23M.

Insider buyers (12 mo): 0
Insider sellers (12 mo): 3
Net insider $ (12 mo): -$11.23M
Congress trades (12 mo): 0
13F moves on file: 3
Analyst ratings on file: 0

BEAM insider buying and selling by quarter

Quarter	Insider sales	Congress buys / sales	13F added / cut
Q1 2026	0	0 / 0	0 / 0
Q2 2026	2 · $10.04M	0 / 0	0 / 3
Q3 2026	0	0 / 0	0 / 0
Q4 2026	3 · $1.19M	0 / 0	0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All BEAM insider, congress, 13F and analyst activity

Date	Source	Who	Action	Shares	Value / amount	ΔOwn	1W	1M	Filing	Story
Oct 16, 2026	Insider	John M. EvansCEO	Sell (Open-market sale) 10b5-1	25K sh	$599.60K	-2.33%			SEC	Read
Oct 15, 2026	Insider	John M. EvansCEO	Sell (Open-market sale) 10b5-1	25K sh	$589.15K	-2.33%			SEC	Read
Oct 1, 2026	Insider	Cavanagh Bethany JSVP, Finance and Treasurer	Sell (Open-market sale) 10b5-1	187 sh	$4.56K		+0.9%			—
Jun 26, 2026	Insider	Fmr LLC	Sell (Open-market sale)	251.49K sh	$8.87M		+1.5%	-28.0%		Read
Jun 25, 2026	Insider	Fmr LLC	Sell (Open-market sale)	33.37K sh	$1.17M		+2.5%	-26.1%		Read
May 12, 2026	13F	ARK Investment Management	Reduced	-333.76K sh	$416.42M		-16.6%	-6.9%		—
May 7, 2026	13F	Dekabank Deutsche Girozentrale	Sold out	-50K sh			-6.2%	-5.4%		—
May 7, 2026	13F	Dekabank Deutsche Girozentrale	Sold out	-50K sh			-6.2%	-5.4%		—

1W / 1M / 6M = how BEAM moved from the trade or filing date.

Insider trading in BEAM: who is buying and selling

Insider	Role	Trades	Open-market net	Shares held	Last trade
John M. Evans	CEO	2	-$1.19M	1.05M	Oct 16, 2026
Cavanagh Bethany J	SVP, Finance and Treasurer	1	-$4.56K		Oct 1, 2026
Fmr LLC		2	-$10.04M		Jun 26, 2026

Institutions moving BEAM (13F)

Frequently asked questions

Are BEAM insiders buying or selling?

Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 3 insiders made 5 open-market sales worth $11.23M, a net -$11.23M.

What is the latest insider trade in BEAM?

John M. Evans, CEO filed a sell (open-market sale) of 25K sh worth $599.60K on Oct 16, 2026.

Which institutions changed their BEAM positions?

Recent 13F filers moving the stock include Dekabank Deutsche Girozentrale and ARK Investment Management.

Other biotechnology stocks

All stocks Insider cluster buys Top insider purchases Congress 13F institutions

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text